Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Introduction to Genetic Testing

4. Global Genetic Testing Market Overview
     4.1 Market Outlook
     4.2 Genetic Testing Laboratories - Unmet Need Analysis
     4.3 DTC Genetic Testing

5. Disease-Wise Analysis
     5.1 Alzheimer's Disease
     5.2 Cystic Fibrosis
     5.3 Cancer

6. Country-Level Analysis
     6.1 US
            6.1.1 Companion Diagnostics and LDTs
            6.1.2 Economical and Social Impact
            6.1.3 Regulatory Measures
            6.1.4 Step towards DTC Genetic Tests Regulation
            6.1.5 Research and Studies
     6.2 Canada
            6.2.1 World's First Bedside Genetic Test
            6.2.2 Physicians’ Opinion
            6.2.3 Information Privacy
     6.3 UK
            6.3.1 Role of NICE
            6.3.2 Newborn Screening: Five Rare Inherited Diseases
     6.4 Germany
            6.4.1 Pre-implantation Genetic Diagnosis
            6.4.2 RAD51C Mutation Screening

7. Emerging Sectors
     7.1 Next-Generation Sequencing
     7.2 Genomic Biomarkers

8. Competitive Assessment
     8.1 Abbott Laboratories
            8.1.1 Company Overview
            8.1.2 Product Offering
            8.1.3 Financial Overview
            8.1.4 Key Activities
            8.1.5 Strengths & Weaknesses
     8.2 Beckman Coulter
            8.2.1 Company Overview
            8.2.2 Product Offering
            8.2.3 Financial Overview
            8.2.4 Key Activities
            8.2.5 Strengths & Weaknesses
     8.3 Roche Diagnostics
            8.3.1 Company Overview
            8.3.2 Product Offering
            8.3.3 Financial Overview
            8.3.4 Key Activities
            8.3.5 Strengths & Weaknesses
     8.4 Myriad Genetics
            8.4.1 Company Overview
            8.4.2 Product Offering
            8.4.3 Financial Overview
            8.4.4 Key Activities
            8.4.5 Strengths & Weaknesses
     8.5 Life Technologies Corporation
            8.5.1 Company Overview
            8.5.2 Product Offering
            8.5.3 Financial Overview
            8.5.4 Key Activities
            8.5.5 Strengths & Weaknesses
     8.6 Genomic Health
            8.6.1 Company Overview
            8.6.2 Product Offering
            8.6.3 Financial Overview
            8.6.4 Key Activities
            8.6.5 Strengths & Weaknesses
     8.7 Sequenom
            8.7.1 Company Overview
            8.7.2 Product Offering
            8.7.3 Financial Overview
            8.7.4 Key Activities
            8.7.5 Strengths & Weaknesses
     8.8 Transgenomic
            8.8.1 Company Overview
            8.8.2 Product Offering
            8.8.3 Financial Overview
            8.8.4 Key Activities
            8.8.5 Strengths & Weaknesses
     8.9 Dako (Agilent Technologies)
            8.9.1 Company Overview
            8.9.2 Product Offering
            8.9.3 Financial Overview
            8.9.4 Key Activities
            8.9.5 Strengths & Weaknesses
     8.10 Gen-Probe (Hologic)
            8.10.1 Company Overview
            8.10.2 Product Offering
            8.10.3 Financial Overview
            8.10.4 Key Activities
            8.10.5 Strengths & Weaknesses
     8.11 Quest Diagnostics
            8.11.1 Company Overview
            8.11.2 Products Offerings
            8.11.3 Financial Overview
            8.11.4 Key Activities
            8.11.5 Strengths & Weaknesses
     8.12 Genoptix (Novartis)
            8.12.1 Company Overview
            8.12.2 Product Offerings
            8.12.3 Financial Overview
            8.12.4 Key Activities
            8.12.5 Strengths & Weaknesses
     8.13 Clarient (GE Healthcare)
            8.13.1 Company Overview
            8.13.2 Product Offerings
            8.13.3 Financial Overview
            8.13.4 Key Activities
            8.13.5 Strengths & Weaknesses